Primary cutaneous aggressive epidermotropic cytotoxic CD8: long‐term remission after brentuximab vedotin+: long‐term remission after brentuximab vedotin T‐cell lymphoma: long‐term remission after brentuximab vedotin

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles